Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harder

Showing results (31-40 of 207) with videos related to

Pageof 21
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
Concentration/effect analysis of verapamil: evaluation of different approachesS Harder, S Rietbrock, P Thürmann
European Journal of Clinical Pharmacology|January 1, 1997
Structure and activities of hospital drug committees in GermanyP A Thürmann, S Harder, A Steioff
Praxis Und Klinik Der Pneumologie|June 1, 1985
[Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease]S Harder, A H Staib, J Stauder
International Journal of Clinical Pharmacology and Therapeutics|May 4, 2007
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065aJ Graff, B Picard-Willems, S Harder
European Journal of Clinical Pharmacology|January 1, 1995
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)P Thürmann, S Harder, C M Kirchmaier
Praxis Und Klinik Der Pneumologie|August 1, 1986
[Individual theophylline doses following ambulatory determination of theophylline clearance]S Harder, A H Staib, J Stauder
Clinical Pharmacokinetics|February 16, 1999
Clinical pharmacokinetics of sevofluraneM Behne, H J Wilke, S Harder
Arzneimittel-Forschung|January 1, 1992
[Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]P G Merz, P Thürmann, S Harder
Arzneimittel-Forschung|July 1, 1991
[Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system]T Huber, P G Merz, S Harder
British Journal of Clinical Pharmacology|May 13, 1998
Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patientsS Harder, P A Thürmann, W Ungethüm
Pageof 21

Showing results (31-40 of 207) with videos related to

Sort By:
Pageof 21
International Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1993
Concentration/effect analysis of verapamil: evaluation of different approachesS Harder, S Rietbrock, P Thürmann
European Journal of Clinical Pharmacology|January 1, 1997
Structure and activities of hospital drug committees in GermanyP A Thürmann, S Harder, A Steioff
Praxis Und Klinik Der Pneumologie|June 1, 1985
[Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease]S Harder, A H Staib, J Stauder
International Journal of Clinical Pharmacology and Therapeutics|May 4, 2007
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065aJ Graff, B Picard-Willems, S Harder
European Journal of Clinical Pharmacology|January 1, 1995
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)P Thürmann, S Harder, C M Kirchmaier
Praxis Und Klinik Der Pneumologie|August 1, 1986
[Individual theophylline doses following ambulatory determination of theophylline clearance]S Harder, A H Staib, J Stauder
Clinical Pharmacokinetics|February 16, 1999
Clinical pharmacokinetics of sevofluraneM Behne, H J Wilke, S Harder
Arzneimittel-Forschung|January 1, 1992
[Biological availability and pharmacodynamics following single oral administration or three different sustained-release isosorbide-5-mononitrate dosage forms]P G Merz, P Thürmann, S Harder
Arzneimittel-Forschung|July 1, 1991
[Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system]T Huber, P G Merz, S Harder
British Journal of Clinical Pharmacology|May 13, 1998
Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patientsS Harder, P A Thürmann, W Ungethüm
Pageof 21